|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����Ǵ�,ϵͳ�� |
|
�������� |
|
���� |
| ��������������� | |
|
�»� |
|
л�츶 |
| PubMed | |
|
Article by |
|
Article by |
ϵͳ�Ժ���Ǵ����ߵ����������������о�
�»�, л�츶
���ϴ�ѧ����ҽԺƤ���Բ��� ��ɳ 410008
����ҽѧģʽ�ɴ�ͳ�ĵ�������ҽѧģʽ������-����-���ҽѧģʽ��ת���ϵͳ�Ժ���Ǵ���������ʱ����ӳ�,���������ѳ�Ϊ��ϵͳ�Ժ���Ǵ��ٴ����ƺ��о�����Ҫ����ĩ����ָ���Ŀǰ���������Ŀ�ġ����������������ĸ������,ϵͳ�Ժ���Ǵ�����������������ѡ��,������������Ӱ�����ؼ��ٴ�Ӧ��,�Լ�������������ƶ���
[2] Smolen JS, Strand V, Cardiel M, et al. Randomized clinical thals and longitudinal observational studies in systemic lupus erythematosus:consensus on a preliminary core set of outcome domains. J Rheumatol, 1999, 26:504-507.
[3] Abu-Shakra M, Mader R, Langevitz P, et al. Quality of life in systemic lupus erythematosus:a controlled study. J Rheumatol, 1999,26:306-309.
[4] Rubio Valladolid G, Gil Aguado A, Balsa Criado A, et al. Prevalence of psychiatric disturbances' and psychopathologic status in patients with systemic lupus erythematosus. Rev Clin Esp, 1998, 198:61-65.
[5] Stoll T, Stucki G, Malik J, et al. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol, 1997, 24:309-313.
[6] Stoll T, Gordon C, Seifert B,et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol, 1997, 24 :1608-1614.
[7] Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus,1998,7:101-107.
[8] Vu TV, Escalante A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol, 1999, 26:2595-2601.
[9] Sutcliffe N, Clarke AE, Levinton C, et al. Asscqates of health status in patients with systemic lupus erythematosus. J Rheumatol, 1999,26:2352-2356.
[10] Perez-Cuevas JB, Formiga F, Garcia-Carrasco M, et al. A quality of life study in women with systemic lupus erythematosus and its relation to disease activity. An Med Interna, 1999, 16:457-460.
[11] Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol, 1999, 26:1694-1700.
[12] Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol, 2001, 28:525-532.
[13] Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum, 1997,40:47-56.
[14] Dobkin PL, Fortin PR, Joseph L, et al. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res, 1998, 11:23-31.
[15] Da Costa D, Dobkin PL, Pinard L, et al. The role of stress in functional disability among women with systemic lupus erythematosus:a prospective study. Arthritis Care Res, 1999, 12:112-119.
[16] Thumboo J, Fong KY, Chan SP,et al. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol,2000, 27:1414-1420.
[17] Strand V, Aranow C, Cardiel MH, et al. Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.Lupus, 2003,12:677-686.
[18] Rood MJ, Borggreve SE, Huizinga TW. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. J Rheumatol, 2000, 27:2057-2059.
[19] Grootscholten C, Ligtenberg G, Derksen RH, et al. Health-related quality of life in patients with systemic lupus erythematosus:development and validation of a lupus specific symptom checklist. Qual Life Res, 2003, 12:635-644.